相关实验视频

Updated: May 15, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

危险之中:欧洲的艾滋病毒疫苗研发

Roger Tatoud¹, Yves Lévy², Roger Le Grand³

¹Origena Consulting, Ferney Voltaire, France.

PLOS global public health

|April 8, 2025

概括

艾滋病毒疫苗对于结束这一流行病至关重要,但研究资金正在下降. 欧洲对艾滋病毒疫苗研发的持续投资对于公共卫生和经济利益至关重要.

科学领域:

免疫学免疫学免疫学
流行病学流行病学
公共卫生政策公共卫生政策

背景情况:

抗逆转录病毒疗法在预防艾滋病毒方面是有效的,但面临着诸如不平等的获取,耐药性和治疗障碍等挑战.
有效的人类免疫缺陷病毒 (HIV) 疫苗对于全球流行病控制至关重要,补充了现有的预防和治疗策略.

研究的目的:

突出在欧洲持续支持艾滋病毒疫苗研发 (R&D) 的关键需求.
强调艾滋病毒疫苗研发的更广泛的好处,包括创新,卫生安全和经济贡献.

主要方法:

这是一篇观点文章,而不是研究报告.
对艾滋病毒预防和治疗现状的分析.
审查最近停止疫苗试验的影响以及欧洲的资金趋势.

主要成果:

停止主要的HIV疫苗疗效研究引发了对全球和欧洲研发的担忧.
在欧洲,减少对艾滋病毒疫苗研发的资金构成了重大挑战.
持续投资对于克服这些障碍至关重要.

结论:

在欧洲支持艾滋病毒疫苗研发对于疫情控制至关重要.
投资促进创新,加强疫情防控,加强卫生主权.
欧洲对艾滋病毒疫苗研发的投资为公众健康和经济带来了显著的优势.

更多相关视频

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

Published on: May 30, 2013

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...